Categories: DrugHealthTechMedtech
Bright Minds Bio a pharmaceutical company. Our team of neuroscientists, drug developers, and physicians tackling the big problems in mental health and neurology.
Investors 2
Mentions in press and media 5
| Date | Title | Description |
| 04.11.2024 | Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement | VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) announces that further to its news release of October 18, 2024, the Company has closed... |
| 16.10.2024 | Bright Minds Biosciences Stock Surges Almost 1,500% Bright Minds Biosciences (NASDAQ: DRUG) soared 1,445% in a single day, trading over 100 million shares without any news. |
Bright Minds Biosciences (NASDAQ: DRUG), a little-known biotech company, became the talk of the market yesterday after its stock skyrocketed by 1,445% in a single trading session. Typically trading under 1 million shares daily, the stock s... |
| 03.12.2022 | Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) -... |
| 03.06.2021 | Psychedelic healthcare fund Neo Kuma sees early success amid sector growth | The UK’s first investment fund dedicated solely to psychedelic healthcare, Neo Kuma is reporting that a number of its early investments are returning yields between 180% and 680%, with three of the seven companies in its portfolio planning ... |
| - | Psychedelic healthcare fund Neo Kuma sees early success amid sector growth | The UK’s first investment fund dedicated solely to psychedelic healthcare, Neo Kuma is reporting that a number of its early investments are returning yields between 180% and 680%, with three of the seven companies in its portfolio planning ... |
Reviews 0
